Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for NASDAQ stock SUPN Supernus Pharmaceuticals. Dated: 13 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 50.64 and Closed at: 49.95, which is -1.46% of previous session's close. It moved within a range of 49.65 and 50.80
The session was a Bearish session with an average volume of 347400, which is -28.18% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 4 days back on short term averages
Support for tomorrow is 49.23 and resistance for tomorrow is 50.38
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 49.47, 48.98 resistance for tomorrow's hourly charts is 50.62, 51.28
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.82 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.24 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 51.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 49.83 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 46.53 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 50.24 and 200 DMA is at 46.53, while 50 DMA and 100 DMA are at 51.31 and 49.83 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 50.24 and 20 EMA is at 50.84
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Apr | 49.95 | 50.24 | 50.84 |
| 10 Fri Apr | 50.68 | 50.27 | 50.93 |
| 09 Thu Apr | 51.50 | 50.39 | 50.96 |
| 08 Wed Apr | 51.61 | 50.5 | 50.9 |
| 07 Tue Apr | 50.96 | 50.63 | 50.82 |
| 06 Mon Apr | 50.54 | 50.78 | 50.81 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 51.31 and 50 EMA is at 50.86
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Apr | 49.95 | 51.31 | 50.86 |
| 10 Fri Apr | 50.68 | 51.29 | 50.9 |
| 09 Thu Apr | 51.50 | 51.25 | 50.91 |
| 08 Wed Apr | 51.61 | 51.21 | 50.89 |
| 07 Tue Apr | 50.96 | 51.16 | 50.86 |
| 06 Mon Apr | 50.54 | 51.11 | 50.86 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 49.83 and 100 EMA is at 49.8
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Apr | 49.95 | 49.83 | 49.8 |
| 10 Fri Apr | 50.68 | 49.78 | 49.8 |
| 09 Thu Apr | 51.50 | 49.72 | 49.78 |
| 08 Wed Apr | 51.61 | 49.65 | 49.75 |
| 07 Tue Apr | 50.96 | 49.6 | 49.71 |
| 06 Mon Apr | 50.54 | 49.54 | 49.68 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 46.53 and 200 EMA is at 46.85
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Apr | 49.95 | 46.53 | 46.85 |
| 10 Fri Apr | 50.68 | 46.44 | 46.82 |
| 09 Thu Apr | 51.50 | 46.34 | 46.78 |
| 08 Wed Apr | 51.61 | 46.24 | 46.73 |
| 07 Tue Apr | 50.96 | 46.15 | 46.68 |
| 06 Mon Apr | 50.54 | 46.06 | 46.64 |
Xenon Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 6.02% more returns!
Supernus Pharmaceuticals has performed better than Vertex Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
United Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in United Therapeutics, about 7.66% more returns!
Soleno Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Soleno Therapeutics, about 55.84% more returns!
Supernus Pharmaceuticals has performed better than Sol Gel in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Rhythm Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Riot Blockchain has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Riot Blockchain, about 23.64% more returns!
Medpace Holdings has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Medpace Holdings, about 11.2% more returns!
Luminex Corporation has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Luminex Corporation, about 5.28% more returns!
Agios Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 18.95% more returns!
Supernus Pharmaceuticals has performed better than Amarin Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Catalyst Biosciences has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 60.83% more returns!
Supernus Pharmaceuticals has performed better than Caredx Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Celcuity Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Celcuity Inc, about 5.33% more returns!
Supernus Pharmaceuticals has performed better than Dexcom Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Fortress Biotech has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Fortress Biotech, about 6.29% more returns!
Henry Schein has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 0.48% more returns!
Irhythm Technologies has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Irhythm Technologies, about 6.51% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term but the buy signal is initial and weak.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.86 and Supernus Pharmaceuticals SUPN stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


